Eduardo Gutierrez-Abejón (Eduardo Gutiérrez-Abejón, Eduardo Gutiérez-Abejón)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Systematic Review

Interstitial Lung Disease

Systemic Sclerosis

Top Venues

Pharmaceuticals (Basel, Switzerland)

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Diego Fernández-Lázaro, Soledad Arribalzaga, Eduardo Gutierrez-Abejón, Mohammad Ali Azarbayjani, Juan Francisco Mielgo-Ayuso, Enrique Roche
Omega-3 Fatty Acid Supplementation on Post-Exercise Inflammation, Muscle Damage, Oxidative Response, and Sports Performance in Physically Healthy Adults-A Systematic Review of Randomized Controlled Trials. Nutrients 16 (13) (2024)
Diego Fernández-Lázaro, Soledad Arribalzaga, Eduardo Gutierrez-Abejón, Mohammad Ali Azarbayjani, Juan Francisco Mielgo-Ayuso, Enrique Roche
Omega-3 Fatty Acid Supplementation on Post-Exercise Inflammation, Muscle Damage, Oxidative Response, and Sports Performance in Physically Healthy Adults-A Systematic Review of Randomized Controlled Trials. Nutrients 16 (13) (2024)
Diego Fernández-Lázaro, Soledad Arribalzaga, Eduardo Gutierrez-Abejón, Mohammad Ali Azarbayjani, Juan Francisco Mielgo-Ayuso, Enrique Roche
Omega-3 Fatty Acid Supplementation on Post-Exercise Inflammation, Muscle Damage, Oxidative Response, and Sports Performance in Physically Healthy Adults-A Systematic Review of Randomized Controlled Trials. Nutrients 16 (13) (2024)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Diego Fernández-Lázaro, Carlos Domínguez-Ortega, Natalia Busto, Mirian Santamaría-Peláez, Enrique Roche, Eduardo Gutierrez-Abejón, Juan Francisco Mielgo-Ayuso
Influence of N-Acetylcysteine Supplementation on Physical Performance and Laboratory Biomarkers in Adult Males: A Systematic Review of Controlled Trials. Nutrients 15 (11) (2023)
Diego Fernández-Lázaro, María Iglesias-Lázaro, Evelina Garrosa, Saray Rodríguez-García, David Jerves Donoso, Eduardo Gutierrez-Abejón, Conrado Jorge-Finnigan
Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Diego Fernández-Lázaro, María Iglesias-Lázaro, Evelina Garrosa, Saray Rodríguez-García, David Jerves Donoso, Eduardo Gutierrez-Abejón, Conrado Jorge-Finnigan
Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Diego Fernández-Lázaro, María Iglesias-Lázaro, Evelina Garrosa, Saray Rodríguez-García, David Jerves Donoso, Eduardo Gutierrez-Abejón, Conrado Jorge-Finnigan
Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Diego Fernández-Lázaro, María Iglesias-Lázaro, Evelina Garrosa, Saray Rodríguez-García, David Jerves Donoso, Eduardo Gutierrez-Abejón, Conrado Jorge-Finnigan
Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review. Medicina (Kaunas, Lithuania) 59 (2) (2023)
Diego Fernández-Lázaro, Emma Marianne Fiandor, Juan F García, Natalia Busto, Mirian Santamaría-Peláez, Eduardo Gutierrez-Abejón, Enrique Roche, Juan Francisco Mielgo-Ayuso
β-Alanine Supplementation in Combat Sports: Evaluation of Sports Performance, Perception, and Anthropometric Parameters and Biochemical Markers-A Systematic Review of Clinical Trials. Nutrients 15 (17) (2023)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, M Aránzazu Pedrosa-Naudín, Diego Fernández-Lázaro, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, M Aránzazu Pedrosa-Naudín, Eduardo Tamayo, Francisco Javier Álvarez
Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival. Medicina (Kaunas, Lithuania) 58 (6) (2022)
M Aránzazu Pedrosa-Naudín, Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Diego Fernández-Lázaro, Francisco Javier Álvarez
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study. Pharmaceutics 14 (12) (2022)
Diego Fernández-Lázaro, Juan Francisco Mielgo-Ayuso, Gema Santamaría, Eduardo Gutierrez-Abejón, Carlos Domínguez-Ortega, Sandra María García-Lázaro, Jesús Ángel Seco-Calvo
Adequacy of an Altitude Fitness Program (Living and Training) plus Intermittent Exposure to Hypoxia for Improving Hematological Biomarkers and Sports Performance of Elite Athletes: A Single-Blind Randomized Clinical Trial. International journal of environmental research and public health 19 (15) (2022)
M Aránzazu Pedrosa-Naudín, Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Diego Fernández-Lázaro, Francisco Javier Álvarez
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study. Pharmaceutics 14 (12) (2022)
M Aránzazu Pedrosa-Naudín, Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Diego Fernández-Lázaro, Francisco Javier Álvarez
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study. Pharmaceutics 14 (12) (2022)
M Aránzazu Pedrosa-Naudín, Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Diego Fernández-Lázaro, Francisco Javier Álvarez
Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study. Pharmaceutics 14 (12) (2022)
Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Débora Martín-García, Eduardo Tamayo, Francisco Javier Álvarez
A Population-Based Registry Analysis on Hospitalized COVID-19 Patients with Previous Cardiovascular Disease: Clinical Profile, Treatment, and Predictors of Death. Journal of cardiovascular development and disease 8 (12) (2021)
Diego Fernández-Lázaro, Juan Francisco Mielgo-Ayuso, Miguel Del Valle Soto, David P Adams, Eduardo Gutierrez-Abejón, Jesús Ángel Seco-Calvo
Impact of Optimal Timing of Intake of Multi-Ingredient Performance Supplements on Sports Performance, Muscular Damage, and Hormonal Behavior across a Ten-Week Training Camp in Elite Cyclists: A Randomized Clinical Trial. Nutrients 13 (11) (2021)
Eduardo Gutierrez-Abejón, Francisco Herrera-Gómez, Francisco Javier Álvarez
Trends in the use of antihistamines with reference to drivers between 2015 and 2019: A population-based registry analysis. Fundamental & clinical pharmacology 35 (6) (2021)
Francisco Herrera-Gómez, Eduardo Gutierrez-Abejón, Mercedes García-Mingo, Francisco Javier Álvarez
Positivity to Cocaine and/or Benzoylecgonine in Confirmation Analyses for On-Road Tests in Spain. International journal of environmental research and public health 18 (10) (2021)
Eduardo Gutierrez-Abejón, Paloma Criado-Espegel, Francisco Herrera-Gómez, Francisco Javier Álvarez
Population-Based Registry Analysis of Antidiabetics Dispensations: Trend Use in Spain between 2015 and 2018 with Reference to Driving. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Eduardo Gutierrez-Abejón, Eduardo Tamayo, Débora Martín-García, Francisco Javier Álvarez, Francisco Herrera-Gómez
Clinical Profile, Treatment and Predictors during the First COVID-19 Wave: A Population-Based Registry Analysis from Castile and Leon Hospitals. International journal of environmental research and public health 17 (24) (2020)
Francisco Herrera-Gómez, Eduardo Gutierrez-Abejón, Ignacio Ayestarán, Paloma Criado-Espegel, Francisco Javier Álvarez
The Trends in Opioid Use in Castile and Leon, Spain: A Population-Based Registry Analysis of Dispensations in 2015 to 2018. Journal of clinical medicine 8 (12) (2019)